Recent Updates of Immunotherapy for Allergic Rhinitis in Children

• Published in: Current otorhinolaryngology reports 2023, Vol.11 (1), p.37-43
• Main Authors: Lin, Chih-Feng, Lin, Yi-Tsen, Liao, Chun-Kang, Yeh, Te-Huei
• Format: Article
• Language: English
• Subjects: Medicine; Medicine & Public Health; Otorhinolaryngology; Pediatric Otolaryngology: Challenges in Pediatric Otolaryngology (W-C Hsu; Section Editor; Topical Collection on PEDIATRIC OTOLARYNGOLOGY: Challenges in Pediatric Otolaryngology
• ISSN: 2167-583X; 2167-583X
• DOI: 10.1007/s40136-023-00440-x

Purpose of Review Allergen immunotherapy (AIT) is a novel treatment approach with disease-modifying and preventative benefits that are not shared with other strategies for treating allergic illnesses. It has been demonstrated to be safe and effective in children. This review provides the most recent information on AIT in children as well as any pertinent updates. Recent Findings Although there is not a standard way to begin AIT, there are clear indications for AIT. Each case needs to be evaluated on its own by weighing the pros and downsides. AIT has been proven to significantly improve symptoms and quality of life in children with allergic illness, reduce medication use, stop the development of new allergen sensitizations, and stop the progression of allergic rhinitis to asthma. Novel approaches are under investigation to overcome some known AIT disadvantages. Summary This review provides a thorough summary of the most recent research and updates on AIT in children.